Decrease in intravenous antibiotic use with adjunctive aerosolized amikacin treatment in intubated mechanically ventilated patients with Gram-negative pneumonia

Documenti analoghi

• Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia
  di: Luyt, Charles-Edouard, et al.
  Pubblicazione: (2009)
• NKTR-061 (inhaled amikacin) delivers high lung doses in mechanically ventilated patients with pneumonia and in healthy subjects
  di: Eldon, M, et al.
  Pubblicazione: (2008)
• Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial
  di: Liu, Chang, et al.
  Pubblicazione: (2017)
• A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)
  di: Dalia M. El Fawy, et al.
  Pubblicazione: (2020-10-01)
• A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)
  di: El Fawy, Dalia M., et al.
  Pubblicazione: (2020)